SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
89.20    2.50 (2.88%)
Bid:
89.10
Ask:
89.30
Spread: 0.20 (0.224%)
Market Cap: £374.96m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

10 Jun 2010 07:00

RNS Number : 3437N
PZ CUSSONS PLC
10 June 2010
 



10 June 2010

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc today issues the following trading update in respect of the year ended 31 May 2010.

 

Overview

 

PZ Cussons Plc is pleased to confirm that its results for the year ended 31 May 2010 are anticipated to be in line with expectations.

 

The Group's balance sheet remains healthy with a continued net funds position following strong cash generation during the period.

 

Markets

 

Europe

 

In the UK, despite the trading environment remaining competitive and a worsening consumer outlook, an excellent pipeline of innovation has enabled strong profitable growth across the brand ranges of Imperial Leather, Carex, Original Source, Charles Worthington and The Sanctuary.

 

Poland has performed well in the year, whilst the economic situation in Greece has resulted in difficult trading conditions.

 

Asia

 

Effective brand renovation together with favourable market conditions has resulted in strong performance across Australia, Indonesia and The Middle East.

 

Africa

 

In Nigeria, the political environment remains stable with the former Vice President now inaugurated as President ahead of elections scheduled for spring of next year. Economically, liquidity continues to improve and trading during the last few months across Personal Care, Home Care, Electricals and Nutrition has been robust.

 

Major Initiatives

 

In Nigeria, Project Unity, which is the £39m investment in manufacturing and supply chain, is on track for completion within the next few months.

 

The Group's major capital investment programme is therefore almost complete.

 

Preliminary Results

 

Preliminary results for the year ended 31 May 2010 will be announced on Tuesday 27 July 2010.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate London, EC2M 6XB.

 

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh

 

Hogarth Limited Tel: 020 7357 9477

John Olsen / Sarah MacLeod

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUUPQUPUGCB
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.